Hepatoma-derived growth factor: a novel prognostic biomarker in intrah
- This topic has 0 replies, 1 voice, and was last updated 9 years, 10 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.
“HDGF can promote IHCC cells progression, including proliferation, invasion, and angiogenesis, indicating HDGF could become a new promising and potential drug target of IHCC.”
http://link.springer.com/article/10.1007%2Fs13277-014-2651-0
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.